ID   CSES25
AC   CVCL_B836
SY   Cedars Sinai Embryonic Stem cell 25
DR   GEO; GSM1246014
DR   NIHhESC; NIHhESC-11-0122
DR   Wikidata; Q54814604
RX   PubMed=26070610;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0122.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=26070610; DOI=10.1016/j.stemcr.2015.05.006; PMCID=PMC4471824;
RA   Avior Y., Biancotti J.C., Benvenisty N.;
RT   "TeratoScore: assessing the differentiation potential of human
RT   pluripotent stem cells by quantitative expression analysis of
RT   teratomas.";
RL   Stem Cell Reports 4:967-974(2015).
//
RX   PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative p53 mutations.";
RL   Nature 545:229-233(2017).
//